In the Pharmaceutical industry, manufacturers implement Six Sigma in order to reduce their operational costs and ensure great service to their clients. By implementing traditional Six Sigma and Lean Manufacturing, many pharmaceutical companies are able to reduce waste and bring about effective change within the manufacturing process. Instead of having to rely on end-process testing, Six Sigma is enabling companies to predict and eradicate errors and therefore give a much needed boost to operational efficiency. This furthermore increases the chance of quality products and compliance.
Pharma lab environments are ripe for Six Sigma and Lean since they are rich in processes and often depend on batching of supplies and production, a process that is inherently wasteful as it causes companies to stockpile inventories, delay flow of finished goods, and cause inefficient use of resources.
In Blood Systems Laboratories's(BSL) , as an instance ,Failures of tests, missed inspections, incomplete documentation can all result in failure of an entire batch of product. One of the more common projects at BSL, for example, is the prevention of non-usables. BSL has run multiple projects involving non-usables in the last two years involving parameters such the presence of preventable errors, empty testing wells, and contaminated sterilization fluids.
By addressing these problems Anexas was able to help reduce non-useable runs by approximately 38% and saved the lab $40,000 per year. The company estimates it has saved over ten times this amount from all Six Sigma projects combined with the skilled guidance of Anexas.
Some of our Clients from Pharmaceutical Industry :
- Strides Arcolab Ltd.
- Novozymes Denmark
- Novartis Switzerland